Agustina, D., 2008, Kanker Mulut (Kajian Pustaka), MIKGI, 9(2): 87-91.

Cha, J.H., 2012, Allicin Inhibits Cell Growth and Induces Apoptosis in U87MG Human
Glioblastoma Cells through an ERK-dependent Pathway, Oncol. Rep., 28: 41-48.

Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, et al. Ewing’s Sarcoma Family of Tumors:
Current Management. The Oncologist. 2006;11(5):503-19.

Rodríguez-Galindo C, Liu T, Krasin M, Wu J, Billups C, Daw N, et al. Analysis of prognostic factors in Ewing
sarcoma family of tumors: review of St. Jude Children’s Research Hospital studies. Cancer. 2007;110(2):375-84.

Galindo C, Navid F, Khoury J, Krasin M. Ewing sarcoma family of tumors. In: Pappo A, editor. Pediatric bone and
soft tissue sarcomas. Heidelberg: Springer-Verlag; 2006.

Iwamoto Y. Diagnosis and treatment of Ewing’s sarcoma. Jpn J Clin Oncol. 2007;37(2):79-89.

Ferrari S, Bertoni F, Palmerini E, Errani C, Bacchini P, Pignotti E, et al. Predictive factors of histologic response to
primary chemotherapy in patients with Ewing sarcoma. J Pediatr Hematol Oncol. 2007;29(6):364-8.

Cance, L. Mc. Kathrya, Sue E. Huether, Valentina L. Brashers, et al. 2010.

Fibrosarcoma. Pathophysiology The Biologic for Disease in Adultd and Children. 6thEdition. Canada:
Mosby Elsevier. pp : 1591.

Wong, Sandra L. 2008. Diagnosis and Management of Desmoid Tumors and Fibrosarcoma. Journal of
Surgical Oncology. Vol 97. University of Michigan. pp : 554-558.

Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, et al. Management of AIDSrelated

Kaposi’s sarcoma. Lancet Oncol. 2007;8:167−176.
Engels EA, Atkinson JO, Graubard BI, et al. Risk factors for human herpesvirus 8
infection among adults in the United States and evidence for sexual transmission. J Infect
Dis. 2007;196:199−207.
Lanternier F, Lebbé C, Schartz N, et al. Kaposi’s sarcoma in HIV-negative men having
sex with men. AIDS. 2008;22:1163−1168.
Serraino D, De Paoli A, Zucchetto A, et al. The impact of Kaposi sarcoma and non-
Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral
therapies era. Cancer Epidemiol. 2010;34:257−261.